JENAVALVE TECHNOLOGY
JenaValve Technology, Inc. is a medical device company focused on the design, development, and commercialization of innovative transcatheter heart valve solutions for the treatment of patients suffering from heart valve disease. The Companyโs Trilogyโข Heart Valve System is a transcatheter aortic valve replacement (โTAVRโ) system designed to treat patients with symptomatic, severe aortic regurgitation (โARโ) and aortic stenosis (โASโ) in high surgical risk patients. The Trilogy Sy... stem received CE Mark approval in May 2021, providing European physicians, for the first time, a device with true dual-disease treatment capabilities. JenaValve received Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA) to facilitate the review of ALIGN-AR, a pivotal trial in the U.S., as part of its premarket approval (โPMAโ) application for the Trilogy Heart Valve System for the treatment of symptomatic, severe aortic regurgitation (AR) in high surgical risk patients. If approved, Trilogy would become the first and only TAVR system in the U.S. to be indicated for the treatment of AR patients. JenaValve is headquartered in Irvine, California, with additional locations in Leeds, U.K., and Munich, Germany. Additional information is available at www.jenavalve.com. US: CAUTION โ Investigational device. Limited by Federal (or United States) law to investigational use.
JENAVALVE TECHNOLOGY
Industry:
Health Care Manufacturing Medical Device
Founded:
2006-01-01
Address:
Irvine, California, United States
Country:
United States
Website Url:
http://www.jenavalve.com
Total Employee:
101+
Status:
Active
Contact:
949-767-2110
Email Addresses:
[email protected]
Total Funding:
299.07 M USD
Technology used in webpage:
SPF Google Font API Domain Not Resolving Microsoft Exchange Online Office 365 Mail Google Maps Microsoft Azure DNS Google Maps API Unified Layer Google Maps For Work
Similar Organizations
Asklepios BioPharmaceutical
Asklepios BioPharmaceutical is a biotechnology company developing adeno-associated virus (AAV) gene therapies for genetic disorders.
CeQur
CeQur develops and commercializes insulin delivery systems, giving people with type 2 diabetes freedom from multiple daily injections.
InTouch Health
InTouch Health is the leader in Acute Care Telemedicine solutions.
Kerecis
Kerecis develops, manufactures, and markets implants and repair materials for the human body from omega3 rich fish skin.
MediPrint Ophthalmics
MediPrint Ophthalmics is a clinical stage eye care pharmaceutical company.
Strados Labs
Strados Labs innovates respiratory monitoring using smart biosensors and artificial intelligence.
Current Advisors List
Current Employees Featured
Founder
Investors List
Valiance Asset Management
Valiance Asset Management investment in Series C - JenaValve Technology
Qatar Investment Authority
Qatar Investment Authority investment in Series C - JenaValve Technology
Bain Capital Life Sciences
Bain Capital Life Sciences investment in Series C - JenaValve Technology
Venture Incubator
Venture Incubator investment in Series C - JenaValve Technology
Andera Partners
Andera Partners investment in Series C - JenaValve Technology
Cormorant Asset Management
Cormorant Asset Management investment in Series C - JenaValve Technology
RMM
RMM investment in Series C - JenaValve Technology
Innovatus Capital Partners
Innovatus Capital Partners investment in Series C - JenaValve Technology
Peijia Medical
Peijia Medical investment in Series C - JenaValve Technology
Gimv
Gimv investment in Series C - JenaValve Technology
Key Employee Changes
Date | New article |
---|---|
2020-09-28 | JenaValve Technology Appoints Peter L. Spadaro Chief Commercial Officer |
Official Site Inspections
http://www.jenavalve.com Semrush global rank: 2.95 M Semrush visits lastest month: 5.52 K
- Host name: 216-172-185-1.unifiedlayer.com
- IP address: 216.172.185.1
- Location: Houston United States
- Latitude: 29.8284
- Longitude: -95.4696
- Metro Code: 618
- Timezone: America/Chicago
- Postal: 77092

More informations about "JenaValve Technology"
JenaValve Technology - Crunchbase Company Profile โฆ
JenaValve Technology, Inc. is a medical device company focused on the design, development, and commercialization of innovative transcatheter heart valve โฆSee details»
JenaValve Company Profile | Management and Employees List
JenaValve Profile and History JenaValve Technology, Inc., with locations in Irvine, California, Leeds, U.K., and Munich, Germany, develops and manufactures transcatheter aortic valve โฆSee details»
JenaValve Technology 2025 Company Profile: โฆ
Information on valuation, funding, acquisitions, investors, and executives for JenaValve Technology. Use the PitchBook Platform to explore the full profile.See details»
JenaValve Company Profile - Office Locations, Competitors ... - Craft
JenaValve has 5 employees across 3 locations and $162.53 m in total funding,. See insights on JenaValve including office locations, competitors, revenue, financials, executives, subsidiaries โฆSee details»
JenaValve Technology - 2025 Company Profile - Tracxn
Jun 21, 2025 Explore JenaValve Technology's in-depth company profile, including funding details, key investors, leadership, and competitors.See details»
JenaValve Technology - VentureRadar
JenaValve Germany Privately Held JenaValve Technology, Inc., a U.S. corporation with primary operations in Munich, Germany, develops, manufactures and markets transcatheter aortic โฆSee details»
JenaValve โ Rosetta Capital
JenaValve is a leading company in the transcatheter heart valve technology sector and are developing a differentiated valve system to treat aortic regurgitation and aortic stenosis.See details»
JenaValve Technology, Inc. Management Team | Org Chart
JenaValve Technology, Inc. employs 170 employees. The JenaValve Technology, Inc. management team includes John Kilcoyne (CEO), Connie Correa-Thomson (Vice President, โฆSee details»
JenaValve
Redefining what it means to treat patients with severe aortic regurgitation.See details»
Jenavalve - Company Profile | Coldlytics
JenaValve is a medical device company based in the United States that is redefining the treatment of severe aortic regurgitation. The company has developed the Trilogy System, a โฆSee details»
JenaValve Technology - Leadership Team | The Org
The Leadership Team at JenaValve Technology is responsible for setting the strategic direction of the company, overseeing the development and commercialization of innovative TAVI systems. โฆSee details»
JenaValve Technology - Financial Details - Crunchbase
JenaValve Technology is funded by 21 investors. Valiance Asset Management and Qatar Investment Authority are the most recent investors. Which investors participated in the most โฆSee details»
FTC aims to stop Edwardsโ acquisition of JenaValve
21 hours ago The FTC moved to block Edwards Lifesciencesโ buyout of JenaValve and its heart implant for aortic regurgitation, slated for FDA approval this year.See details»
Edwards Lifesciences Comments on FTCโs Action to Block โฆ
2 days ago IRVINE, Calif.-- (BUSINESS WIRE)-- Edwards Lifesciences (NYSE: EW) announced today that the U.S. Federal Trade Commission (FTC) moved to block the companyโs proposed โฆSee details»
FTC Challenges Edwards's Proposed Acquisition of JenaValve
1 day ago FTC Challenges Edwards's Proposed Acquisition of JenaValve The Irvine, CA-based company announced it would acquire JenaValve a little more than a year ago.See details»
Contact Us - JenaValve
Redefining what it means to treat patients with severe aortic regurgitation.See details»
JenaValve CEO and Key Executive Team - Craft.co
JenaValve's CFO is Peter Wulff. Other executives include Victoria E. Carr-Brendel, Ph.D., Chief Executive Officer; Mark Adler, Vice President of Operations and 3 others. See the full โฆSee details»
JenaValve Technology - Profiles & Contacts - Crunchbase
JenaValve Technology Growth Score 89 CB Rank 11153 Heat Score 69 Actions JenaValve is a medical device company focused on the design and development of innovative transcatheter โฆSee details»
Careers : JenaValve
JenaValve is a culture of teamwork, innovation, and integrity We strive to infuse our core company values into every facet of our achievements and day-to-day operations. We honor the sacred โฆSee details»
Investors : JenaValve
Redefining what it means to treat patients with severe aortic regurgitation.See details»